153 related articles for article (PubMed ID: 2297745)
1. Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125.
Lehtovirta P; Kairemo KJ; Liewendahl K; Seppälä M
Cancer Res; 1990 Feb; 50(3 Suppl):937s-940s. PubMed ID: 2297745
[TBL] [Abstract][Full Text] [Related]
2. Immunoscintigraphy of recurrences of gynecologic carcinomas.
Chatal JF; Fumoleau P; Saccavini JC; Thedrez P; Curtet C; Bianco-Arco A; Chetanneau A; Peltier P; Kremer M; Guillard Y
J Nucl Med; 1987 Dec; 28(12):1807-19. PubMed ID: 3500284
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunodetection of lymph node invasion in prostatic cancer. The use of iodine 123 (123I)-labeled monoclonal anti-prostatic acid phosphatase (PAP) 227 A F(ab')2 antibody fragments in vivo.
Leroy M; Teillac P; Rain JD; Saccavini JC; Le Duc A; Najean Y
Cancer; 1989 Jul; 64(1):1-5. PubMed ID: 2731106
[TBL] [Abstract][Full Text] [Related]
4. Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody.
Massuger LF; Kenemans P; Claessens RA; Verheijen RH; Schijf CP; Strijk SP; Poels LG; van Hoesel RG; Corstens FH
J Nucl Med; 1990 Nov; 31(11):1802-10. PubMed ID: 2230993
[TBL] [Abstract][Full Text] [Related]
5. Immunoscintigraphy with 131I-labelled HMFG2 and HMFG1 F(ab')2 in the pre-operative detection of clinical and subclinical lymph node metastases in breast cancer patients.
Athanassiou A; Pectasides D; Pateniotis K; Tzimis L; Natsis P; Lafi A; Arapantoni P; Koutsiouba P; Taylor-Papadimitriou J; Epenetos A
Int J Cancer Suppl; 1988; 3():89-95. PubMed ID: 3209306
[TBL] [Abstract][Full Text] [Related]
6. Immunoscintigraphy of endometriosis.
Kennedy SH; Mojiminiyi OA; Soper ND; Shepstone BJ; Barlow DH
Br J Obstet Gynaecol; 1990 Aug; 97(8):667-70. PubMed ID: 2400745
[TBL] [Abstract][Full Text] [Related]
7. Immunoscintigraphy with 131I or 111In labelled OC 125 F(ab')2 fragments in patients with ovarian carcinoma.
Jiménez-Vicioso A; Torres M; Jiménez-Heffernan A; Grana MD; Latre JM; Llamas JM; Carreras JL; Mateo A
Int J Biol Markers; 1990; 5(4):159-65. PubMed ID: 2093731
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125.
Baum RP; Lorenz M; Hottenrott C; Albrecht M; Senekowitsch R; Happ J; Hertel A; Spitz J; Hör G
Int J Biol Markers; 1988; 3(3):177-84. PubMed ID: 3230337
[TBL] [Abstract][Full Text] [Related]
9. Influence of circulating antigen on blood pool activity of a radioiodinated monoclonal antibody.
Zalutsky MR; Knapp RC; Bast RC
Int J Rad Appl Instrum B; 1988; 15(4):431-7. PubMed ID: 3255739
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of a radioiodinated monoclonal antibody F(ab')2 fragment in a xenograft model with circulating antigen.
Zalutsky MR; Bast RC; Knapp RC
Int J Rad Appl Instrum B; 1989; 16(4):405-11. PubMed ID: 2777582
[TBL] [Abstract][Full Text] [Related]
11. [Immunoscintigraphy of cancer of the ovaries and colon using labeled monoclonal antibodies].
Gabuniia RI; Shiriaev SV; Bogdasarov IuB; Zhordaniia KI; Anan'ev VS
Med Radiol (Mosk); 1989 Aug; 34(8):56-61. PubMed ID: 2770446
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC 125) specific for CA 125 antigen. The INSERM Research Network (Nantes, Rennes, Reims, Vuillejuif, Saclay.
Peltier P; Dutin JP; Chatal JF; Fumoleau P; Bourguet P; Liehn JC; Vuillez JP; Hérry JY; Loboguerrero A
Ann Oncol; 1993 Apr; 4(4):307-11. PubMed ID: 8518221
[TBL] [Abstract][Full Text] [Related]
13. [The detection of metastases of ovarian carcinoma by immunoscintigraphy with monoclonal antibodies].
Peking A; Marinov V
Akush Ginekol (Sofiia); 1990; 29(1):57-60. PubMed ID: 2164792
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments.
Barzen G; Mayr AC; Langer M; Becker R; Cordes M; Zwicker C; Koppenhagen K; Felix R
Eur J Nucl Med; 1989; 15(1):42-8. PubMed ID: 2917583
[TBL] [Abstract][Full Text] [Related]
15. [Basic study for immunoscintigraphy of ovarian cancer using 99mTc labeled F(ab')2 fragments of monoclonal antibody].
Sugiyama S
Kaku Igaku; 1994 Apr; 31(4):327-36. PubMed ID: 8196229
[TBL] [Abstract][Full Text] [Related]
16. [The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma].
Buist MR; Roos JC; Vermorken JB; Golding RP; Burger CW; Kenemans P
Ned Tijdschr Geneeskd; 1991 Jan; 135(4):126-30. PubMed ID: 2002855
[TBL] [Abstract][Full Text] [Related]
17. Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.
Buraggi GL; Callegaro L; Mariani G; Turrin A; Cascinelli N; Attili A; Bombardieri E; Terno G; Plassio G; Dovis M
Cancer Res; 1985 Jul; 45(7):3378-87. PubMed ID: 4005860
[TBL] [Abstract][Full Text] [Related]
18. Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma.
Manil L; Boudet F; Motte P; Gardet P; Saccavini JC; Lumbroso JD; Schlumberger M; Caillou B; Bazin JP; Ricard M
Cancer Res; 1989 Oct; 49(19):5480-5. PubMed ID: 2766309
[TBL] [Abstract][Full Text] [Related]
19. Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125.
Muto MG; Lepisto EM; Van den Abbeele AD; Knapp RC; Kassis AI
Am J Obstet Gynecol; 1989 Nov; 161(5):1206-12. PubMed ID: 2686446
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the diagnostic usefulness of CA125 immunoscintigraphy for ovarian carcinoma follow-up after treatment: contribution of this technique in Grenoble University Medical Center].
Vuillez JP; Levrot E; Mousseau M; Buffaz PD; Bolla M; Payan R; Comet M; Schaerer R
Bull Cancer; 1997 Nov; 84(11):1033-42. PubMed ID: 9536985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
